Cancer immunotherapy turns viral

被引：9
作者：
Galluzzi, Lorenzo [1 ,2 ,3 ]
Lugli, Enrico [4 ]
机构：
[1] Univ Paris 05, Sorbonne Paris Cite, Paris, France
[2] Ctr Rech Cordeliers, Equipe Labelisee Ligue Natl Canc 11, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Humanitas Clin & Res Inst, Unit Clin & Expt Immunol, Rozzano, Italy
来源：
ONCOIMMUNOLOGY | 2013年 / 2卷 / 04期
关键词：
Amgen; OncoVEX(GM-CSF); clinical trials; immunotherapy; melanoma; talimogene laherparepvec; HERPES-SIMPLEX-VIRUS; MONOCLONAL-ANTIBODIES; THERAPY; VIROTHERAPY; MELANOMA; TRIAL;
D O I：
10.4161/onci.24802
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 18 条
  • [1] Ligand-targeted therapeutics in anticancer therapy
    Allen, TM
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 750 - 763
  • [2] Oncolytic adenoviruses A potent form of tumor immunovirotherapy
    Cerullo, Vincenzo
    Vaha-Koskela, Markus
    Hemminki, Akseli
    [J]. ONCOIMMUNOLOGY, 2012, 1 (06) : 979 - 981
  • [3] Combining targeted therapy with immunotherapy (interferon-α) Rational, efficacy in gastrointestinal stromal tumor model and implications in other malignancies
    Chen, Lei L.
    Gouw, Launce
    Sabripour, Mahyar
    Hwu, Wen-Jen
    Benjamin, Robert S.
    [J]. ONCOIMMUNOLOGY, 2012, 1 (05) : 773 - 776
  • [4] Strategies for optimizing combinations of molecularly targeted anticancer agents
    Dancey, Janet E.
    Chen, Helen X.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (08) : 649 - 659
  • [5] Two Hundred Years of Cancer Research
    DeVita, Vincent T., Jr.
    Rosenberg, Steven A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23) : 2207 - 2214
  • [6] BRAF inhibition improves tumor recognition by the immune system Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
    Donia, Marco
    Fagone, Paolo
    Nicoletti, Ferdinando
    Andersen, Rikke Sick
    Hogdall, Estrid
    Straten, Per Thor
    Andersen, Mads Hald
    Svane, Inge Marie
    [J]. ONCOIMMUNOLOGY, 2012, 1 (09) : 1476 - 1483
  • [7] Trial watch Monoclonal antibodies in cancer therapy
    Galluzzi, Lorenzo
    Vacchelli, Erika
    Fridman, Wolf Herve
    Galon, Jerome
    Sautes-Fridman, Catherine
    Tartour, Eric
    Zucman-Rossi, Jessica
    Zitvogel, Laurence
    Kroemer, Guido
    [J]. ONCOIMMUNOLOGY, 2012, 1 (01): : 28 - 37
  • [8] The secret ally: immunostimulation by anticancer drugs
    Galluzzi, Lorenzo
    Senovilla, Laura
    Zitvogel, Laurence
    Kroemer, Guido
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 215 - 233
  • [9] A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
    Hu, Jennifer C. C.
    Coffin, Robert S.
    Davis, Ceri J.
    Graham, Nicola J.
    Groves, Natasha
    Guest, Peter J.
    Harrington, Kevin J.
    James, Nicholas D.
    Love, Colin A.
    McNeish, Iain
    Medley, Louise C.
    Michael, Agnieszka
    Nutting, Christopher M.
    Pandha, Hardev S.
    Shorrock, Claire A.
    Simpson, Julie
    Steiner, Jan
    Steven, Neil M.
    Wright, Dennis
    Coombes, R. Charles
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (22) : 6737 - 6747
  • [10] Kaufman HL, 2010, FUTURE ONCOL, V6, P941, DOI [10.2217/fon.10.66, 10.2217/FON.10.66]
12